Conmed Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2018
January 22, 2019 at 09:01 pm
Share
CONMED Corporation announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced sales was USD 242.444 million compared to USD 222.555 million a year ago. Operating income was USD 25.822 million compared to USD 23.175 million a year ago. Net income was USD 15.653 million compared to USD 46.696 million a year ago. Basic earnings per share was USD 0.56 compared to USD 1.67 a year ago. Diluted earnings per share was USD 0.54 compared to USD 1.65 a year ago. For the full year, sales was USD 859.634 million compared to USD 796.392 million a year ago. Operating income was USD 71.305 million compared to USD 46.935 million a year ago. Net income was USD 40.854 million compared to USD 55.487 million a year ago. Basic earnings per share was USD 1.45 compared to USD 1.99 a year ago. Diluted earnings per share was USD 1.41 compared to USD 1.97 a year ago.
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.